830 related articles for article (PubMed ID: 12921494)
21. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
Loder E; Freitag FG; Adelman J; Pearlmand S; Abu-Shakra S
Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
[TBL] [Abstract][Full Text] [Related]
22. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
[TBL] [Abstract][Full Text] [Related]
23. Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.
Mauskop A; Farkkila M; Hering-Hanit R; Rapoport A; Warner J
Curr Med Res Opin; 1999; 15(4):282-9. PubMed ID: 10640260
[TBL] [Abstract][Full Text] [Related]
24. Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.
Edmeads JG; Millson DS
Cephalalgia; 1997 Oct; 17 Suppl 18():41-52. PubMed ID: 9399016
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.
Cittadini E; May A; Straube A; Evers S; Bussone G; Goadsby PJ
Arch Neurol; 2006 Nov; 63(11):1537-42. PubMed ID: 16966497
[TBL] [Abstract][Full Text] [Related]
26. A long-term study to maximise migraine relief with zolmitriptan.
Tepper SJ; Donnan GA; Dowson AJ; Bomhof MA; Elkind A; Meloche J; Fletcher PE; Millson DS
Curr Med Res Opin; 1999; 15(4):254-71. PubMed ID: 10640258
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers.
Yates R; Nairn K; Dixon R; Kemp JV; Dane AL
J Clin Pharmacol; 2002 Nov; 42(11):1244-50. PubMed ID: 12412823
[TBL] [Abstract][Full Text] [Related]
28. Zolmitriptan provides consistent migraine relief when used in the long-term.
Tuchman M; Edvinsson L; Geraud G; Korczyn A; Mauskop A; Pfaffenrath V
Curr Med Res Opin; 1999; 15(4):272-81. PubMed ID: 10640259
[TBL] [Abstract][Full Text] [Related]
29. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older.
McKeage K
Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634
[TBL] [Abstract][Full Text] [Related]
30. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
31. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
Hedlund C; Rapoport AM; Dodick DW; Goadsby PJ
Headache; 2009 Oct; 49(9):1315-23. PubMed ID: 19788472
[TBL] [Abstract][Full Text] [Related]
32. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
Rapoport AM; Mathew NT; Silberstein SD; Dodick D; Tepper SJ; Sheftell FD; Bigal ME
Neurology; 2007 Aug; 69(9):821-6. PubMed ID: 17724283
[TBL] [Abstract][Full Text] [Related]
33. Review of zolmitriptan and its clinical applications in migraine.
Dowson AJ; Charlesworth B
Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
[TBL] [Abstract][Full Text] [Related]
34. 311C90: long-term efficacy and tolerability profile for the acute treatment of migraine. International 311C90 Long-Term Study Group.
Zagami AS
Neurology; 1997 Mar; 48(3 Suppl 3):S25-8. PubMed ID: 9071267
[TBL] [Abstract][Full Text] [Related]
35. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
Stöckli HR; Sword A
Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
[TBL] [Abstract][Full Text] [Related]
36. Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study.
Sakai F; Iwata M; Tashiro K; Itoyama Y; Tsuji S; Fukuuchi Y; Sobue G; Nakashima K; Morimatsu M
Cephalalgia; 2002 Jun; 22(5):376-83. PubMed ID: 12110113
[TBL] [Abstract][Full Text] [Related]
37. Spotlight on almotriptan in migraine.
Keam SJ; Goa KL; Figgitt DP
CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
[TBL] [Abstract][Full Text] [Related]
38. Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
Spierings EL; Brandes JL; Kudrow DB; Weintraub J; Schmidt PC; Kellerman DJ; Tepper SJ
Cephalalgia; 2018 Feb; 38(2):215-224. PubMed ID: 29022755
[TBL] [Abstract][Full Text] [Related]
39. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
Dowson AJ; MacGregor EA; Purdy RA; Becker WJ; Green J; Levy SL
Cephalalgia; 2002 Mar; 22(2):101-6. PubMed ID: 11972576
[TBL] [Abstract][Full Text] [Related]
40. Almotriptan: a review of its use in migraine.
Keam SJ; Goa KL; Figgitt DP
Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
